Prostate Cancer- Stage Dictates Prognosis

Share Button

Prostate cancer- stage dictates prognosis, meaning that your therapy plan depends largely on both your stage at diagnosis as well as your personal goals.

i am a long-term survivor of an incurable blood cancer. For the past 25 or so years, my life has been dominated by therapy-induced long-term and late-stage side effects. When I talk about your stage and your life goals, I’m talking about balancing length of life with quality of life.

With prostate cancer, treatment often leads directly to short-term and long-term side effects. Radiation, androgen deprivation therapy, prostatectomy, etc., can treat your cancer, but they can cause serious side effects such as urinary incontinence, heart damage, and erectile dysfunction.



I am not trying to discourage you from undergoing treatment; I’m encouraging you to understand your prognosis and how the treatment you choose can cause possible side effects.

Prehabilitation before you undergo any type of treatment can reduce your risk of side effects. 

Read more about prostate cancer-

Have you been diagnosed with prostate cancer? What stage? To learn more about evidence-based, non-conventional prostate cancer therapies, scroll down the page, post a question or a comment, and I will reply to you ASAP.

Good luck,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

The Four Main Stages

    • Stage I (Localized):

      Cancer cells are only in the prostate and are small, often undetectable except through biopsy. 

    • Stage II (Localized):

      Cancer is still confined to the prostate but might involve more of the gland, classified as IIA, IIB, or IIC depending on tumor size and if it’s in both sides. 

    • Stage III (Locally Advanced):

      Cancer has grown outside the prostate capsule into nearby tissues, like the seminal vesicles (Stage IIIA/IIIB). 

  • Stage IV (Metastatic/Advanced):

    Cancer has spread to distant lymph nodes or other organs (bones, liver, lungs). 

  • Stage IVA: Spread to nearby lymph nodes.
  • Stage IVB: Spread to distant parts of the body (bones, organs). 
How Staging Works (TNM & Grading)
  • T (Tumor): Describes the size and local spread within the prostate (e.g., T2 inside, T3 outside). 
  • N (Nodes): Indicates if cancer has spread to lymph nodes (N0 = none, N1 = present). 
  • M (Metastasis): Shows if cancer has spread to distant sites (M0 = none, M1 = present). 
  • Gleason Score & Grade Groups: Assess how aggressive cells look under a microscope (Grade Group 1 is least aggressive, 5 is most aggressive), replacing older Gleason scoring (e.g., Gleason 6 is Grade Group 1, Gleason 7 is Grade Group 2 or 3). 
Risk Groups & Prognosis
  • Doctors combine TNM, Grade Group, and PSA levels into risk groups (low, intermediate, high) to predict behavior. 
  • Stages I-III often aim for cure, while Stage IV treatment focuses on prolonging life and managing symptoms. 

Prostate cancer is highly survivable, especially when caught early, with nearly 100% 5-year survival for localized/regional stages and excellent long-term outlooks (98% 10-year survival). Survival rates decrease with advanced stages (e.g., around 50% for stage 4, metastatic), but treatments have improved, offering good control and longer lives, though recurrence is possible, requiring ongoing monitoring.

Survival Rates by Stage (5-Year Survival)

  • Localized (within prostate): Over 99%.
  • Regional (spread to nearby areas/nodes): Over 99%.
  • Distant (spread to bones, lungs, liver, etc.): Around 31-50%, depending on the source, but improving. 
Key Factors Affecting Outlook
  • Early Detection:
    Crucial for the best prognosis; regular screenings (PSA, DRE) for at-risk men (over 55, Black men, family history) are important. 

  • Cancer Grade & Stage:
    More aggressive cancers (higher Gleason score) or those that have spread have a worse outlook. 

  • Treatment Response:
    How well the cancer responds to surgery, radiation, hormone therapy, etc., significantly impacts survival. 

  • Overall Health:
    Other health conditions (like heart disease) can affect treatment options and overall life expectancy. 

Long-Term Outlook & Recurrence
  • Many men live long lives after treatment, but prostate cancer can recur years later, even after successful initial treatment, making long-term follow-up vital. 
  • Advanced prostate cancer (metastatic) has a more challenging prognosis, but new therapies offer hope for controlling the disease for extended periods. 

Prostate cancer- stage dictates prognosis Prostate cancer- stage dictates prognosis Prostate cancer- stage dictates prognosis

Leave a Comment: